
A data-driven strategy can assess the quality of legacy drugs developed before 2011 process-validation requirements were established.
Robert Rhoades is managing partner at Validant.

A data-driven strategy can assess the quality of legacy drugs developed before 2011 process-validation requirements were established.

July 2nd 2021